Pharma Market in Belgium Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Belgium Pharmaceutical Industry Overview & Analysis. The Market is Segmented by ATC/Therapeutic Class (Alimentary Tract and Metabolism?, Blood and Blood Forming Organs?, Cardiovascular System?, Dermatological?s, Genito Urinary System and Sex Hormones?, Systemic Hormonal Preparations?, Anti-infectives for Systemic Use?, Antineoplastic and Immunomodulating Agents?, Musculoskeletal System?, Nervous System?, Antiparasitic Products, Insecticides, and Repellents?, Respiratory System?, Sensory Organs?, and Other Therapeutic Classes) and Drug Type (Prescription Drugs (Branded and Generics) and OTC)). The market size and forecasts are provided in terms of value (USD million) for all the above segments.

Pharma Market in Belgium Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Belgium Pharmaceutical Industry Overview

The Belgium pharmaceutical market is highly competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some prominent players are vigorously making acquisitions and joint ventures with other companies to consolidate their market positions in the country. Some of the key companies currently dominating the market are AbbVie Inc., AstraZeneca PLC, Bayer AG, C.H. Boehringer Sohn AG & Ko. KG, and GlaxoSmithKline PLC, among others.

Belgium Pharmaceutical Market Leaders

  1. C.H. Boehringer Sohn AG & Ko. KG

  2. AstraZeneca plc

  3. AbbVie Inc.

  4. Bayer AG

  5. GlaxoSmithKline plc

  6. *Disclaimer: Major Players sorted in no particular order
AbbVie Inc.,  AstraZeneca PLC, Bayer AG, C.H. Boehringer Sohn AG & Ko. KG, GlaxoSmithKline PLC, F. Hoffmann-La Roche AG, Bristol Myers Squibb Company